课题基金 / 基金详情

Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease

Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease
富含亮氨酸重复激酶 2 与显性遗传性帕金森病
批准号:
8552524
负责人:
Mark Cookson
金额:
$64.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Mark Cookson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Leucine rich repeat kinase 2 (LRRK2) mutations are causal for inherited Parkinsons disease with age-dependent penetrance. The protein is a large complex kinase with several reported protein interactions and mutliple proposed functions. Some mutations increase kinase activity, and the overall aim of this project is to extend our prior observations that kinase activity of LRRK2 is important in pathogenesis association with mutations in this gene. In the past reporting period, we have spent some time characterizing highly purified LRRK2 protein, and the related homolog LRRK1. We find that both proteins form dimers, which we had previously suggested but has been controversial. One possibility, which we are pursuing, is that there are protein binding partners and/or conformational states of LRRK2 that prevent this from happening within cells. We were also able to confirm our previous observations with partially purified material, that the Parkinson's disease associated LRRK2 protein is a more active kinase than the homolog LRRK1. The significance of this observation is not yet clear. We have also characterized a risk factor variant for LRRK2, G2385R, which we found surprisingly has lower kinase activity than wild type protein. The likely mechanism is that G2385R alters intramolecular interactions within the large, complex protein. This work may have implications for the types of therapeutics that should be developed for LRRK2-related disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alpha Synuclein, cellular dysfunction and Parkinson disease
  • 批准号:
    8552517
  • 项目类别:
  • 资助金额:
    $17.49万
  • 财政年份:
    --
  • 负责人:
    Mark Cookson
  • 依托单位:
Gene expression in the human brain
  • 批准号:
    8736661
  • 项目类别:
  • 资助金额:
    $25.35万
  • 财政年份:
    --
  • 负责人:
    Mark Cookson
  • 依托单位:
DJ-1 function and oxidative stress
  • 批准号:
    8552528
  • 项目类别:
  • 资助金额:
    $34.98万
  • 财政年份:
    --
  • 负责人:
    Mark Cookson
  • 依托单位:
Alpha Synuclein, cellular dysfunction and Parkinson disease
  • 批准号:
    8736655
  • 项目类别:
  • 资助金额:
    $42.24万
  • 财政年份:
    --
  • 负责人:
    Mark Cookson
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: